Press releases

Month Year

Email alerts

Feb 4, 2015

Medtronic Starts U.S. Launch Of IN.PACT Admiral Drug-Coated Balloon For Treatment Of Peripheral arterial Disease In Upper Leg

First Uses of New Medical Device Following FDA Approval Take Place at Hospitals Nationwide

DUBLIN – Feb. 4, 2015 – U.S. hospitals this week began using a new medical device from Medtronic plc (NYSE: MDT) called the IN.PACT Admiral drug-coated balloon (DCB) to treat patients with...
Jan 29, 2015

Studies Show Benefits of Medtronic SmartShock(TM) Technology and Physician Reports in Protecting Patients from Inappropriate Shocks

New Results from PainFree SST, Shock-Less Studies, Involving Nearly 7,000 Patients, Published in HeartRhythm

DUBLIN and MINNEAPOLIS - Jan. 29, 2015 - Medtronic plc (NYSE: MDT) today announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm. The data...
Jan 5, 2015

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

Pivotal Study Shows New Medical Device Provides Exceptional Clinical Outcomes and Reduces Need for Costly Repeat Procedures

MINNEAPOLIS -- Jan. 5, 2015 -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's IN.PACT Admiral drug-coated balloon (DCB) for...
Dec 30, 2014

Announcement under Irish Takeover Rules Relevant Securities in Issue – December 3, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 3, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
Dec 30, 2014

Announcement under Irish Takeover Rules Relevant Securities in Issue – December 30, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 30, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa